CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 151.2 SEK -3.82% Market Closed
Market Cap: 3.6B SEK

CellaVision AB
Total Receivables

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

CellaVision AB
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
CellaVision AB
STO:CEVI
Total Receivables
kr154.1m
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
14%
Elekta AB (publ)
STO:EKTA B
Total Receivables
kr7.4B
CAGR 3-Years
-2%
CAGR 5-Years
2%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Total Receivables
kr211.6m
CAGR 3-Years
2%
CAGR 5-Years
67%
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Total Receivables
kr8.2B
CAGR 3-Years
11%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Total Receivables
kr2.2B
CAGR 3-Years
6%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Total Receivables
kr90.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

CellaVision AB
Glance View

CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

CEVI Intrinsic Value
230.62 SEK
Undervaluation 34%
Intrinsic Value
Price

See Also

What is CellaVision AB's Total Receivables?
Total Receivables
154.1m SEK

Based on the financial report for Sep 30, 2025, CellaVision AB's Total Receivables amounts to 154.1m SEK.

What is CellaVision AB's Total Receivables growth rate?
Total Receivables CAGR 10Y
14%

Over the last year, the Total Receivables growth was 9%. The average annual Total Receivables growth rates for CellaVision AB have been 8% over the past three years , 7% over the past five years , and 14% over the past ten years .

Back to Top